Number of respondents by (selected*) first cancer site and date of diagnosis: Fee-For-Service

This table provides information about number of CAHPS survey respondents in SEER-CAHPS by selected first cancer sire and time between diagnosis and survey.

First cancer Total number of SEER linked patients First survey before month of first cancer diagnosis First survey within 2 years of first cancer diagnosis First survey within 3–5 years of first cancer diagnosis First survey within 6–10 years of first cancer diagnosis First survey within 11+ years of first cancer diagnosis
N % N % N % N % N %
Prostate 51,756 16,240 31.38 7,166 13.85 7,614 14.71 11,188 21.62 9,548 18.45
Breast 51,298 18,112 35.31 6,126 11.94 6,776 13.21 9,569 18.65 10,715 20.89
Lung and Bronchus 28,268 21,212 75.04 3,155 11.16 1,718 6.08 1,451 5.13 732 2.59
Colorectal 26,596 12,195 45.85 3,484 13.10 3,180 11.96 4,016 15.10 3,721 13.99
Melanoma Skin 20,377 8,824 43.30 2,561 12.57 2,570 12.61 3,171 15.56 3,251 15.95
Bladder 15,637 7,882 50.41 2,135 13.65 1,834 11.73 2,129 13.62 1,657 10.60
Non-Hodgkins Lymphoma 11,495 5,902 51.34 1,507 13.11 1,356 11.80 1,552 13.50 1,178 10.25
Uterine Corpus 8,652 3,082 35.62 1,022 11.81 1,087 12.56 1,506 17.41 1,955 22.60
Kidney/Renal Pelvis 8,641 4,284 49.58 1,118 12.94 1,054 12.20 1,230 14.23 955 11.05
Head/Neck 7,558 3,626 47.98 982 12.99 922 12.20 1,085 14.36 943 12.48
Leukemia 7,476 4,267 57.08 991 13.26 785 10.50 861 11.52 572 7.65
Pancreas 5,841 5,159 88.32 410 7.02 122 2.09 103 1.76 47 0.80
Stomach 3,130 2,141 68.40 338 10.80 216 6.90 254 8.12 181 5.78
Ovary 2,976 1,586 53.29 399 13.41 297 9.98 296 9.95 398 13.37
Liver/Bile Duct 2,827 2,227 78.78 292 10.33 147 5.20 115 4.07 46 1.63
Esophagus 1,957 1,437 73.43 226 11.55 118 6.03 98 5.01 78 3.99
Uterine Cervix 943 294 31.18 101 10.71 97 10.29 156 16.54 295 31.28

* Sites reflect most prevalent cancer sites in SEER-CAHPS.

Last Updated: 25 Jun, 2025